Individual tests

The aPTT is one of several blood coagulation tests. It measures how long it takes your blood to form a clot. When one of your blood vessels is damaged, proteins called clotting factors come together to form clots and quickly stop the bleeding. The aPTT test helps assess how well those clotting factors work, often in conjunction with other tests that monitor clotting factors.
A blood smear is a sample spread on a glass slide and treated with a special stain. Previously, all blood smears were examined under a microscope by laboratory professionals. Now automated digital systems can help examine blood smears. A blood smear helps diagnose and monitor conditions such as blood disorders, sudden kidney failure, and certain cancer treatments.
A complete blood count is a screening test for various disease states including anemia, leukemia, and inflammatory processes. This test is analyzed based on blood from the cord.
A complete blood count is a common blood test that is often part of a routine checkup. This test can help detect a variety of disorders, including infections, anemia, immune system disease, and blood cancers.
A complete blood count is a common blood test in routine checkups. This test can help detect various disorders, including infections and anemia. A reticulocyte count measures the number of immature red blood cells (reticulocytes) in your bone marrow to find out if you are producing enough red blood cells.
The direct Coombs test detects antibodies stuck to the surface of red blood cells. Many diseases and drugs can cause this to happen. These antibodies sometimes destroy red blood cells, causing anemia. Your healthcare provider may recommend this test if you have signs or symptoms of anemia or jaundice (yellowing of the skin or eyes).
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder affecting red blood cells, which carry oxygen from the lungs to tissues throughout the body. The disease can cause hemolysis, where red blood cells are destroyed faster than the body can replace them.
Hepatitis A virus (HAV) is one of the most common causes of liver inflammation. When first infected with HAV, your immune system produces IgM antibodies, which appear in your blood 5 to 10 days before symptoms appear. They can stay in your blood for about six months after infection, with IgG antibodies remaining for life.
Hepatitis A virus is one of the most common causes of liver inflammation. Your immune system makes antibodies when you are first infected with HAV. IgM Antibodies often begin to appear in the blood 5 to 10 days before symptoms appear. They can stay in your blood for about six months after the infection. Some antibodies called IgG can last in your blood for life.
Hepatitis A is commonly spread by eating or drinking contaminated food or water. This may happen if an infected person doesn't wash their hands after using the bathroom. Most people recover from hepatitis A without lasting liver damage. This test detects the presence of HAV antibodies, which indicate prior or acute infection with, or immunization to, the hepatitis A virus.
The Hepatitis B virus (HBV) is a common cause of liver inflammation. Your immune system makes IgM antibodies against HBV that appear in your blood several weeks after infection. People with the hepatitis B vaccine will not have this antibody in their blood. The test determines whether you are actively infected with the hepatitis B virus (HBV).
The quantitative test of hepatitis B core antibody level distinguishes cases of hepatitis antibodies from vaccination with those with a history of cured acute hepatitis B. This test can also be used with other hepatitis immunological indicators to evaluate treatment effectiveness in hepatitis B patients.
The hepatitis B virus (HBV) is one of the major causes of liver inflammation. The hepatitis B e antigen (HBeAg) appears after an HBV infection. Usually, HBeAg indicates much higher rates of viral replication and enhanced infectivity. However, variants of the hepatitis B virus do not produce the 'e' antigen, so this rule does not always hold. The HBeAg may be cleared, and antibodies to the 'e' antigen (anti-HBe) will arise immediately afterward, suggesting a dramatic decline in viral replication.
This is a viral protein made by the hepatitis B virus that is released from infected liver cells into the blood. A positive HBeAg indicates high virus levels in the blood, with the person considered infectious. A negative result indicates very low to no virus in the blood, and the person is considered less infectious; sometimes, this can indicate a person has a mutant hepatitis B virus.
loading.svg